BAX
Healthcare · Medical Instruments & Supplies
Performance
BAX (BAX) Stock Analysis 2026
Rule-based · Updated daily · Not financial advice
BAX (BAX) operates in the Medical Instruments & Supplies space within the Healthcare sector. With a market cap of $10.7B, it qualifies as a mid-cap company. Growth is moderate and the business remains profitable, offering a balanced risk/reward profile compared to high-multiple peers.
- Low beta of 0.64 — less volatile than the market, suitable for conservative portfolios
- Negative profit margin of -9.7% — company is currently unprofitable
- Negative ROE of -15.0% — shareholder equity is being eroded
- High debt-to-equity of 161.02× increases financial risk, especially with elevated interest rates
Verdict
Avoid
Significant fundamental concerns outweigh positives. High risk at current levels.
AI Insight
Powered by ClaudeAI-generated analysis for informational purposes only. Not financial advice.
Related Articles
Revenue & Results
Dividends
Current DY
0.96%
5Y Avg Annual
$0.7780
Last Payment
$0.0100
Ex-Date
05/29/2026
Annual dividends paid per share
| Ex-Date | Payment | Amount | Est. DY |
|---|---|---|---|
Latest05/29/2026 | 07/01/2026 | $0.0100 | 0.19% |
02/27/2026 | 04/01/2026 | $0.0100 | 0.19% |
11/28/2025 | 12/31/2025 | $0.0100 | 0.19% |
08/29/2025 | 10/01/2025 | $0.1700 | 3.28% |
05/30/2025 | 07/02/2025 | $0.1700 | 3.28% |
02/28/2025 | 04/02/2025 | $0.1700 | 3.28% |
11/29/2024 | 01/01/2025 | $0.1700 | 3.28% |
08/30/2024 | 10/02/2024 | $0.2900 | 5.60% |
Magic Number
Shares needed to self-fund your next purchase
$20.73
Price
$0.0100
Last div. (quarterly)
2,073
shares
Own 2,073 BAX shares ($42,973.29) and each quarterly dividend pays for 1 new share — the snowball runs on its own.
Investment target
$42,973.29
New shares / year
+4 shares
If You Had Invested…
Hypothetical return based on historical prices
* Dividend reinvestment calculated at ex-date price. For informational purposes only.
Earnings
Next Earnings
Jul 30, 2026
44
days
EPS (TTM)
$-1.91
P/E (TTM)
—
Fwd P/E
10.3
Earnings History
SEC EDGAR · official filings
SEC Filings
Official EDGAR documents
Key Statistics
Valuation
Trading
Dividends
Profitability
Balance Sheet
Fair Value Estimates
Current price: $20.73
Graham Number
√(22.5 × EPS × Book Value)
N/A
Benjamin Graham's intrinsic value formula. Assumes a fair stock trades at no more than 22.5× the product of EPS and book value per share.
Bazin Ceiling Price
Avg. Annual DPS (5Y) ÷ 6%
$16.52
Décio Bazin's dividend-based ceiling. The max price you should pay so that dividends alone deliver at least 6% annual yield on your cost basis.
These are simplified estimates. Not financial advice.
Buy & Hold Checklist
Quality criteria for long-term holding
6/10
67% score
Pays dividends
15Y hist.15+ years of dividend history
Dividend consistency (5Y+)
15 yrsUninterrupted dividend payments for at least 5 years
ROE above 10%
-15.0%Return on equity — measures how efficiently capital is used
Positive profit margin
-9.7%Net profit margin must be positive — company earns more than it spends
Revenue growth (annual)
+2.9%Annual revenue must be growing compared to the prior year
Earnings growth (annual)
Annual earnings must be growing compared to the prior year
Debt/Equity below 2×
161.02×Low financial leverage reduces risk of distress
Current ratio above 1
1.85×Short-term assets must cover short-term liabilities
Daily liquidity above $5M
$158M/dayHigh trading volume ensures easy entry and exit
Dividend yield above 0%
0.96%Stock must distribute income to shareholders
Related Assets
Healthcare
About BAX
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Location
Deerfield, United States
Employees
37,500